Vivek Subbiah
0000-0002-6064-6837
Publication & Citation Trends
Most Cited Works
Publications
1,427 total
Abstract CT192: Orally administered MOMA-313 as monotherapy or combination therapy in participants with advanced or metastatic solid homologous recombination (HR)-deficient tumors: Phase 1 study design
Cited by 0
Semantic Scholar
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter study
Cited by 0
Semantic Scholar
Abstract CT109: A first-in-human phase 1 study of LY4050784, an oral, potent, and selective SMARCA2 inhibitor, in patients with advanced solid tumors with SMARCA4 alterations (Trial in Progress)
Cited by 1
Semantic Scholar
Abstract P4-08-24: AKTive-001: A Phase 1/1b Multiple Cohort Trial of ALTA2618 in Patients with Advanced Solid Tumors with AKT1 E17K Mutation (Trial in Progress)
Cited by 1
Semantic Scholar
Abstract CT195: A phase 1 dose escalation/expansion study of GSK5764227, a B7-homolog 3 protein targeted antibody-drug conjugate, in combination with standard of care in patients with advanced solid tumors
Cited by 0
Semantic Scholar
A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours OA
Cited by 0
Semantic Scholar
A phase-1 dose escalation and expansion study of EP0031, a next-generation selective RET inhibitor (SRI), in patients with SRI-naïve or pretreated advanced RET-altered NSCLC and other tumors.
Cited by 2
Semantic Scholar
Lurbinectedin is an effective alternative to platinum rechallenge and may restore platinum sensitivity in patients with sensitive relapsed small cell lung cancer OA
Cited by 1
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(333)
Lung Cancer Treatments and Mutations
(297)
Sarcoma Diagnosis and Treatment
(148)
Cancer Immunotherapy and Biomarkers
(137)
Colorectal Cancer Treatments and Studies
(132)
Frequent Co-Authors
Affiliations
Twitter (United States)
Texas A&M Health Science Center
Roswell Park Comprehensive Cancer Center
All India Institute of Medical Sciences Raipur
National Institutes of Health